| 英文名称 |
中文名称 |
CAS号 |
操作 |
| ACT-777991 |
|
1967811-46-6 |
详细
|
| Presatovir |
GS-5806 |
1353625-73-6 |
详细
|
| NSC745887 |
化合物 T8082 |
54490-26-5 |
详细
|
| Mbx2329 |
1-(2-(2-乙基苯氧基)乙基)氮杂环庚烷盐酸盐 |
1438272-42-4 |
详细
|
| Nalmefene hydrochloride |
盐酸纳美芬 |
58895-64-0 |
详细
|
| Datelliptium chloride |
2-[2-(二乙氨基)乙基]-9-羟基-5,11-二甲基-6H-吡啶并[4,3-B]咔唑 |
105118-14-7 |
详细
|
| RPT-193 |
化合物 RPT193 |
2366152-15-8 |
详细
|
| SEQ-9 |
|
|
详细
|
| SelDeg51 |
|
|
详细
|
| AEF0117 |
AEF0117 |
1610878-71-1 |
详细
|
| CARDIN |
维司那定 |
477-32-7 |
详细
|
| MTOB |
4-甲硫基-2-氧丁酸钠 |
51828-97-8 |
详细
|
| Iclepertin |
BI-425809 |
1421936-85-7 |
详细
|
| SRI31215 |
SRI-31215 BIS-TFA SALT |
1832686-44-8 |
详细
|
| Dextrorphan tartrate |
去甲右美沙芬酒石酸盐 |
143-98-6 |
详细
|
| KAN0438757 |
KAN0438757 |
1451255-59-6 |
详细
|
| MK-0616 |
DALOTUZUMAB ( 达罗托组单抗 ) |
1005389-60-5 |
详细
|
| Trovirdine |
曲韦定 |
149488-17-5 |
详细
|
| TP0472993 |
化合物CYP4A11/CYP4F2-IN-2 |
2126874-77-7 |
详细
|
| MTK458 |
MTK458 |
2499962-58-0 |
详细
|
| PROTAC-O4I2 |
化合物PROTAC-O4I2 |
2785323-62-6 |
详细
|
| CH7233163 |
|
2923365-71-1 |
详细
|
| JNT-517 |
JNT-517 |
2837993-05-0 |
详细
|
| polynta1 |
|
|
详细
|
| Taraxasterol acetate |
蒲公英甾醇醋酸酯 |
6426-43-3 |
详细
|
| navoximod |
1402837-78-8 |
1402837-78-8 |
详细
|
| (RS)-PPG |
4-磷酰基苯甘氨酸 |
120667-15-4 |
详细
|
| MK-8722 |
MK-8722 |
1394371-71-1 |
详细
|
| Takeda103A |
Takeda103A |
865609-72-9 |
详细
|
| PSB 0777 ammonium salt |
|
2122196-16-9 |
详细
|
| Paramethasone Acetate |
帕拉米松乙酸酯 |
1597-82-6 |
详细
|
| SJFδ |
SJFδ |
2254609-23-7 |
详细
|
| PD151746 |
PD151746 |
179461-52-0 |
详细
|
| PYR01 |
|
2560576-15-8 |
详细
|
| CA77.1 |
化合物CA77.1 |
2412270-22-3 |
详细
|
| Zunsemetinib |
ZUNSEMETINIB |
1640282-42-3 |
详细
|
| ALV1 |
化合物 ALV1 |
2438124-79-7 |
详细
|
| PF-6870961 |
|
2857112-06-0 |
详细
|
| OICR12694 |
JNJ-65234637 |
2360625-97-2 |
详细
|
| QR-6401 |
|
2845096-18-4 |
详细
|
| PF-07202954 |
PF-07202954 |
2639372-47-5 |
详细
|
| Tubacin |
HDAC6 抑制剂 |
537049-40-4 |
详细
|
| PE859 |
PE859 |
1402727-29-0 |
详细
|
| acoramidis |
1446711-81-4 |
1446711-81-4 |
详细
|
| ALV2 |
|
2438124-95-7 |
详细
|
| Maresin 1 |
7(R)-Maresin 1 |
1268720-28-0 |
详细
|
| AV-105 |
(E)-2-[2-[2-[[5-[4-[BOC-(甲基)氨基]苯乙烯基]-2-吡啶基]氧基]乙氧基]乙氧基]乙基-4-甲基苯磺酸酯 |
1205550-99-7 |
详细
|
| IACS-010759 |
5-(5-甲基-1-(3-(4-(甲基磺酰基)哌啶-1-基)苄基)-1H-1,2,4-三唑-3-基)-3-(4-(三氟甲氧基)苯基)-1,2,4-恶二唑 |
1570496-34-2 |
详细
|
| RGX-104 |
RGX-104 |
610318-54-2 |
详细
|
| Fasnall |
FASNALL |
929978-58-5 |
详细
|
| SB218078 |
SB218078 |
135897-06-2 |
详细
|
| DNL343 |
|
2278265-85-1 |
详细
|
| Amibegron hydrochloride |
121524-09-2 |
121524-09-2 |
详细
|
| KIN-3248 |
|
2750709-24-9 |
详细
|
| BMS-502 |
BMS-502 (COMPOUND 22) |
2407854-18-4 |
详细
|
| EOS789 |
|
|
详细
|
| HRO761 |
|
|
详细
|
| 2-(CHLOROMETHYL)-5-PHENYL-1,3-OXAZOLE |
|
64640-13-7 |
详细
|
| Dalcetrapib |
CETP抑制剂 |
211513-37-0 |
详细
|
| PS 1145 dihydrochloride |
N-(6-CHLORO-9H-PYRIDO[3,4-B]INDOL-8-YL)-3-PYRIDINECARBOXAMIDE DIHYDROCHLORIDE |
1049743-58-9 |
详细
|
| UM-164 |
UM-164 |
903564-48-7 |
详细
|
| NCGC607 |
NCGC607 |
1462267-07-7 |
详细
|
| MK-8189 |
4-PYRIMIDINAMINE, 2-METHYL-6-[[(1S,2S)-2-(5-METHYL-2-PYRIDINYL)CYCLOPROPYL]METHOXY]-N-[(5-METHYL-1,3 |
1424371-93-6 |
详细
|
| ST1006 |
化合物 T34709 |
1196994-11-2 |
详细
|
| BDM2 |
|
1643876-33-8 |
详细
|
| TP0473292 |
|
|
详细
|
| STX-721 |
|
2765525-82-2 |
详细
|
| (R)-Viloxazine Hydrochloride |
(R)-维洛沙嗪盐酸盐 |
56287-63-9 |
详细
|
| KO-947 |
KO-947 |
1695533-89-1 |
详细
|
| NSC31150 |
NSC 31150 |
51244-45-2 |
详细
|
| Z-YVAD-FMK |
MVPQJUFFTWWKBT-LBDWYMBGSA-N |
210344-97-1 |
详细
|
| RPW-24 |
RPW-24 |
1001625-82-6 |
详细
|
| XPC-6444 |
XPC-6444 |
2230144-21-3 |
详细
|
| muvalaplin |
莫伐倍林 |
2565656-70-2 |
详细
|
| PF-07258669 |
|
|
详细
|
| GLPG2534 |
化合物GLPG2534 |
2095615-97-5 |
详细
|
| KCL-286 |
化合物KCL-286 |
1952276-71-9 |
详细
|
| arazasetron (SENS-401) |
SENS-401 |
2025360-91-0 |
详细
|
| GIBH-130 |
GIBH-130 |
1252608-59-5 |
详细
|
| Retro 2 |
化合物RETRO 2 |
1201652-50-7 |
详细
|
| NVS-ZP7-4 |
NVS-ZP7-4 |
2349367-89-9 |
详细
|
| 6PNG |
2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one |
68682-01-9 |
详细
|
| ML-209 |
3-(1,3-Benzodioxol-5-yl)-1-(cis-3,5-dimethyl-1-piperidinyl)-3-(2-hydroxy-4,6-dimethoxyphenyl)-1-propanone |
1334526-14-5 |
详细
|
| lirafugratinib (RLY4008) |
RLY-4008 盐酸盐 |
2688040-45-9 |
详细
|
| JT001 |
(2R,3R,4R,5R)-2-(4-氨基吡咯并[2.1-F][1.2.4]三嗪-7-基-5-D)-2-氰基-5-((异丁酰氧基)甲基)四氢呋喃-3,4-二基双(2-甲基丙酸酯)氢溴酸盐 |
2779498-79-0 |
详细
|
| WDR5 PROTAC MS40 |
|
|
详细
|
| TAK-994 |
|
2861934-86-1 |
详细
|
| 6-Hydroxybenzofuran-2(3H)-one |
6-羟基苯并呋喃-2(3H)-酮 |
2688-49-5 |
详细
|
| Delavirdine |
地拉韦啶 |
136817-59-9 |
详细
|
| MDL 12330A hydrochloride |
MDL-12,330A HYDROCHLORIDE |
40297-09-4 |
详细
|
| OBI-3424 |
OBI-3424 |
2097713-68-1 |
详细
|
| Baxdrostat |
BAXDROSTAT |
1428652-17-8 |
详细
|
| KW-6356 |
化合物 SIPAGLADENANT |
858979-50-7 |
详细
|
| BAY-747 |
|
1609342-18-8 |
详细
|
| NT-0796 |
(R)-2-(((1,2,3,5,6,7-六氢-S-引达省-4-基)氨基甲酰基)氧基)-3-(嘧啶-2-基)丙酸异丙酯 |
2272917-13-0 |
详细
|
| PIK5-12d |
|
|
详细
|
| TAE-1 |
2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide |
1414469-59-2 |
详细
|
| ziritaxestat |
GLPG-1690 |
1628260-79-6 |
详细
|
| AMG986 |
Azelaprag |
2049980-18-7 |
详细
|
| Adenosine A1 receptor activator T62 |
T62 |
40312-34-3 |
详细
|